Navidea Biopharmaceuticals Debt to Equity Ratio 2006-2020 | NAVB

Current and historical debt to equity ratio values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Navidea Biopharmaceuticals debt/equity for the three months ending June 30, 2020 was 0.00.
Navidea Biopharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-06-30 $0.01B $0.00B 2.89
2020-03-31 $0.01B $-0.00B -5.10
2019-12-31 $0.01B $-0.00B -5.71
2019-09-30 $0.01B $0.00B -53.01
2019-06-30 $0.01B $0.00B 1.77
2019-03-31 $0.01B $0.00B 51.43
2018-12-31 $0.01B $0.00B 1.91
2018-09-30 $0.01B $0.00B 3.53
2018-06-30 $0.01B $0.00B 2.11
2018-03-31 $0.01B $0.01B 2.70
2017-12-31 $0.01B $0.01B 0.73
2017-09-30 $0.01B $0.02B 0.41
2017-06-30 $0.01B $0.02B 0.49
2017-03-31 $0.01B $0.02B 0.47
2016-12-31 $0.08B $-0.07B -1.18
2016-09-30 $0.08B $-0.06B -1.18
2016-06-30 $0.07B $-0.06B -1.14
2016-03-31 $0.07B $-0.06B -1.22
2015-12-31 $0.07B $-0.05B -1.28
2015-09-30 $0.07B $-0.05B -1.34
2015-06-30 $0.07B $-0.05B -1.50
2015-03-31 $0.05B $-0.04B -1.31
2014-12-31 $0.04B $-0.03B -1.40
2014-09-30 $0.05B $-0.03B -1.56
2014-06-30 $0.05B $-0.02B -1.99
2014-03-31 $0.05B $-0.02B -3.23
2013-12-31 $0.04B $-0.00B -11.06
2013-09-30 $0.04B $0.01B 4.63
2013-06-30 $0.03B $-0.00B -17.98
2013-03-31 $0.02B $-0.00B -6.00
2012-12-31 $0.01B $-0.00B -9.52
2012-09-30 $0.01B $0.00B 3.94
2012-06-30 $0.01B $0.01B 1.02
2012-03-31 $0.01B $0.02B 0.68
2011-12-31 $0.01B $0.02B 0.48
2011-09-30 $0.01B $0.03B 0.17
2011-06-30 $0.01B $0.01B 0.97
2011-03-31 $0.01B $0.01B 0.64
2010-12-31 $0.01B $0.00B 1.63
2010-09-30 $0.01B $0.00B 5.26
2010-06-30 $0.01B $0.00B 1.92
2010-03-31 $0.02B $-0.01B -1.84
2009-12-31 $0.02B $-0.01B -1.91
2009-09-30 $0.02B $-0.01B -1.89
2009-06-30 $0.04B $-0.03B -1.28
2009-03-31 $0.02B $-0.02B -1.60
2008-12-31 $0.01B $-0.00B -4.18
2008-09-30 $0.01B $-0.00B -5.29
2008-06-30 $0.01B $0.00B -81.55
2008-03-31 $0.01B $-0.00B -4.43
2007-12-31 $0.01B $-0.00B -2.79
2007-09-30 $0.01B $-0.00B -3.90
2007-06-30 $0.01B $-0.00B -4.07
2007-03-31 $0.01B $-0.00B -6.10
2006-12-31 $0.01B $0.00B -27.96
2006-09-30 $0.01B $0.00B 9.68
2006-06-30 $0.01B $0.00B 3.02
2006-03-31 $0.01B $0.00B 2.30
2005-12-31 $0.01B $0.00B 1.88
2005-09-30 $0.01B $0.01B 1.31
2005-06-30 $0.01B $0.01B 1.08
2005-03-31 $0.01B $0.01B 0.86
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.075B $0.001B
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $171.820B 32.61
Intuitive Surgical (ISRG) United States $81.091B 72.86
Edwards Lifesciences (EW) United States $48.689B 43.51
DexCom (DXCM) United States $38.506B 132.73
IDEXX Laboratories (IDXX) United States $32.751B 72.79
Olympus (OCPNY) Japan $27.830B 72.50
ALCON INC (ALC) Switzerland $27.774B 49.47
Fresenius Medical Care AG KGaA (FMS) Germany $25.316B 16.32
Sysmex ADR (SSMXY) Japan $19.987B 66.50
Hologic (HOLX) United States $17.124B 25.63
SONOVA HOLDING (SONVY) Switzerland $16.354B 0.00
Varian Medical Systems (VAR) United States $15.642B 43.00
Teleflex (TFX) United States $15.608B 30.78
STERIS (STE) Ireland $14.699B 30.21
Masimo (MASI) United States $12.765B 66.56
ABIOMED (ABMD) United States $12.274B 73.24
SARTORIUS AG (SARTF) Germany $11.598B 99.71
Penumbra (PEN) United States $6.985B 1137.94
Tandem Diabetes Care (TNDM) United States $6.859B 0.00
Elekta AB (EKTAY) Sweden $4.842B 37.28
Globus Medical (GMED) United States $4.782B 38.20
Nevro (NVRO) United States $4.760B 0.00
Wright Medical Group (WMGI) Netherlands $3.966B 0.00
Integra LifeSciences Holdings (IART) United States $3.912B 21.39
Nihon Kohden (NHNKY) Japan $2.689B 27.22
ShockWave Medical (SWAV) United States $2.534B 0.00
OPKO Health (OPK) United States $2.298B 0.00
Silk Road Medical (SILK) United States $2.296B 0.00
Glaukos (GKOS) United States $2.277B 0.00
LivaNova (LIVN) United Kingdom $2.111B 21.47
Integer Holdings (ITGR) United States $1.927B 14.60
Cantel Medical (CMD) United States $1.883B 26.91
Veracyte (VCYT) United States $1.659B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.580B 35.53
Pacific Biosciences Of California (PACB) United States $1.513B 0.00
Mesa Laboratories (MLAB) United States $1.306B 64.45
Luminex (LMNX) United States $1.216B 114.00
GenMark Diagnostics (GNMK) United States $0.995B 0.00
OrthoPediatrics (KIDS) United States $0.906B 0.00
CryoLife (CRY) United States $0.702B 308.83
Tactile Systems Technology (TCMD) United States $0.694B 595.83
Si-Bone (SIBN) United States $0.661B 0.00
Inogen (INGN) United States $0.643B 67.77
Accelerate Diagnostics (AXDX) United States $0.609B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.597B 73.57
Natus Medical (NTUS) United States $0.572B 23.15
Fluidigm (FLDM) United States $0.548B 0.00
Intersect ENT (XENT) United States $0.538B 0.00
ViewRay (VRAY) United States $0.484B 0.00
AngioDynamics (ANGO) United States $0.483B 424.67
AxoGen (AXGN) United States $0.467B 0.00
Alphatec Holdings (ATEC) United States $0.442B 0.00
Quotient (QTNT) Switzerland $0.420B 0.00
SeaSpine Holdings (SPNE) United States $0.390B 0.00
TransMedics (TMDX) United States $0.375B 0.00
Semler Scientific (SMLR) United States $0.342B 43.70
Vermillion (AWH) United States $0.338B 0.00
Repro Med Systems (KRMD) United States $0.315B 143.60
Oxford Immunotec Global (OXFD) United Kingdom $0.307B 0.00
IRadimed (IRMD) United States $0.259B 49.21
Stereotaxis (STXS) United States $0.248B 0.00
Accuray (ARAY) United States $0.219B 0.00
T2 Biosystems (TTOO) United States $0.191B 0.00
Sientra (SIEN) United States $0.168B 0.00
CRH Medical (CRHM) Canada $0.149B 0.00
DarioHealth (DRIO) Israel $0.140B 0.00
EDAP TMS S.A (EDAP) France $0.135B 464.00
Neuronetics (STIM) United States $0.095B 0.00
Restoration Robotics (VERO) Canada $0.094B 0.00
MRI Interventions (CLPT) United States $0.091B 0.00
Electromed (ELMD) United States $0.091B 22.10
Spectral Diagnostics (EDTXF) Canada $0.080B 0.00
ConforMIS (CFMS) United States $0.067B 0.00
Bioanalytical Systems (BASI) United States $0.054B 0.00
Neovasc (NVCN) Canada $0.048B 0.00
Delcath Systems (DCTH) United States $0.044B 0.00
Sensus Healthcare (SRTS) United States $0.043B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.043B 0.00
Apollo Endosurgery (APEN) United States $0.040B 0.00
Ekso Bionics Holdings (EKSO) United States $0.037B 0.00
TransEnterix (TRXC) United States $0.035B 0.00
Avinger (AVGR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.025B 0.00
Allied Healthcare Products (AHPI) United States $0.022B 0.00
CHF Solutions (CHFS) United States $0.022B 0.00
Ra Medical Systems (RMED) United States $0.021B 0.00
Second Sight Medical Products (EYES) United States $0.021B 0.00
ReWalk Robotics (RWLK) Israel $0.021B 0.00
ENDRA Life Sciences (NDRA) United States $0.019B 0.00
Helius Medical Technologies (HSDT) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.011B 0.00
InspireMD (NSPR) Israel $0.010B 0.00
Xtant Medical Holdings (XTNT) United States $0.010B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
Viveve Medical (VIVE) United States $0.008B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
OBALON THERPTCS (OBLN) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00